Overview

Meclizine as a Potential Smoking Cessation Treatment

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether meclizine, an antihistamine used to prevent or treat motion sickness, can help smokers quit smoking. This study will also investigate the potential relationship between genes you have inherited and success in quitting smoking.
Phase:
Phase 2
Details
Lead Sponsor:
Duke University
Collaborator:
Philip Morris USA, Inc.
Treatments:
Meclizine
Nicotine